{"groups":[{"description":"Cetuximab 400 mg/m\\^2 as an initial dose, followed by 250 mg/m\\^2 intravenously (IV) every 7 days.","id":"FG000","title":"Cetuximab"},{"description":"Panitumumab 6 mg/kg IV every 14 days.","id":"FG001","title":"Panitumumab"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"}],"type":"Ineligibility determined"},{"reasons":[{"groupId":"FG000","numSubjects":"19"},{"groupId":"FG001","numSubjects":"20"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"14"},{"groupId":"FG001","numSubjects":"17"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"391"},{"groupId":"FG001","numSubjects":"384"}],"type":"Death"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"504"},{"groupId":"FG001","numSubjects":"506"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"500"},{"groupId":"FG001","numSubjects":"499"}],"type":"Received Treatment"},{"achievements":[{"comment":"Indicates participants continuing in study","groupId":"FG000","numSubjects":"78"},{"comment":"Indicates participants continuing in study","groupId":"FG001","numSubjects":"85"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"426"},{"groupId":"FG001","numSubjects":"421"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"First patient enrolled on 2nd February 2010 and last patient enrolled 19 July 2012.\n\nResults are reported as of the data cut-off date of 5 February 2013."}